Jason Cavalier - Net Worth and Insider Trading

Jason Cavalier Net Worth

The estimated net worth of Jason Cavalier is at least $4 Million dollars as of 2025-07-23. Jason Cavalier is the CFO of Lyra Therapeutics Inc and owns about 519,316 shares of Lyra Therapeutics Inc (LYRA) stock worth over $4 Million. Details can be seen in Jason Cavalier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Cavalier has not made any transactions after 2025-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Jason Cavalier

To

Jason Cavalier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Cavalier owns 1 companies in total, including Lyra Therapeutics Inc (LYRA) .

Click here to see the complete history of Jason Cavalier’s form 4 insider trades.

Insider Ownership Summary of Jason Cavalier

Ticker Company Transaction Date Type of Owner
LYRA Lyra Therapeutics Inc 2025-07-10 Chief Financial Officer

Jason Cavalier Latest Holdings Summary

Jason Cavalier currently owns a total of 1 stock. Jason Cavalier owns 519,316 shares of Lyra Therapeutics Inc (LYRA) as of July 10, 2025, with a value of $4 Million.

Latest Holdings of Jason Cavalier

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LYRA Lyra Therapeutics Inc 2025-07-10 519,316 8.62 4,473,907

Holding Weightings of Jason Cavalier


Jason Cavalier Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Cavalier has made a total of 1 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lyra Therapeutics Inc is the sale of 684 shares on July 10, 2025, which brought Jason Cavalier around $6,094.

Insider Trading History of Jason Cavalier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Cavalier Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jason Cavalier Ownership Network

Ownership Network List of Jason Cavalier

No Data

Ownership Network Relation of Jason Cavalier

Insider Network Chart


Jason Cavalier Owned Company Details

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Jason Cavalier is the Chief Financial Officer of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & President & CEO Maria Palasis , director & Executive Chair Harlan Waksal , and 10 percent owner Nbvm Gp, Llc .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Jason Cavalier made 1 insider transaction in Lyra Therapeutics Inc (LYRA) with a net sale of 684. Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net sale of 1,565 shares made by Maria Palasis ,

In summary, during the past 3 months, insiders sold 2,249 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 2,249 shares. During the past 18 months, 2,249 shares of Lyra Therapeutics Inc (LYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,249 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lyra Therapeutics Inc Insider Transactions

No Available Data

Jason Cavalier Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Cavalier. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jason Cavalier's mailing address is: Watertown Ma 02472.